Clarity expands its pipeline with a novel optimised FAP-targeted radiopharmaceutical
Highlights Clarity has developed a proprietary fibroblast activation protein (FAP)-targeted radiopharmaceutical product that can be used with the perfect pairing of copper isotopes for the diagnosis and treatment of cancer. The product, termed...
When ancient cures meet smart tech: Level up your health
BEIJING, Dec. 1, 2024 /PRNewswire/ -- This is a report from China.org.cn. Join presenter Jason Dane Castleton at the Health and Wellness pavilion of the second China International Supply Chain Expo, where innovations from traditional medicine to...